R. Marzo

发表

Quantification of HBG mRNA in primary erythroid cultures: prediction of the response to hydroxyurea in sickle cell and beta‐thalassemia

M. Steinberg, R. Calzolari, A. Maggio, 2014, European journal of haematology.

Modifier Genes in the Haemoglobinopathies

R. Calzolari, A. Maggio, D. Rund, 2010 .

Treatment with hydroxycarbamide for intermedia thalassaemia: decrease of efficacy in some patients during long‐term follow up

A. Mancuso, A. Maggio, D. Renda, 2006, British journal of haematology.

Clinical severity of non‐deletion form of HbH disease (——Med/ααthal)

A. Maggio, A. Giambona, S. Acuto, 2009 .

βA and βthal DNA haplotypes in Sicily

A. Maggio, A. Giambona, S. Acuto, 1986, Human Genetics.

αααanti-4.2 Haplotype and heterozygous β° thalassemia in a Sicilian family

B. Saitta, A. Maggio, A. Giambona, 2004, Human Genetics.

The Autoinflammatory Diseases Alliance Registry of monogenic autoinflammatory diseases

L. Dotta, B. Ogunjimi, F. Shahram, 2022, Frontiers in Medicine.

Cyclospora in AIDS patients: not always an agent of diarrhoic syndrome.

M. Panaro, G. Angarano, P. Maggi, 1995, The new microbiologica.

Desensitization to hydroxycarbamide following long‐term treatment of thalassaemia intermedia as observed in vivo and in primary erythroid cultures from treated patients

R. Calzolari, A. Maggio, A. Pecoraro, 2010, British journal of haematology.

Efficacy of Rapamycin as Inducer of Hb F in Primary Erythroid Cultures from Sickle Cell Disease and β-Thalassemia Patients

R. Calzolari, A. Martorana, A. Maggio, 2015, Hemoglobin.

Allele-specific transcription of fetal genes in primary erythroid cell cultures from Lepore and δβ° thalassemia patients

R. Calzolari, A. Maggio, S. Acuto, 2005 .

A genetic strategy to treat sickle cell anemia by coregulating globin transgene expression and RNA interference

M. Sadelain, J. Tisdale, P. Zhu, 2006, Nature Biotechnology.

The spectrum of β‐thalassaemia mutations in Sicily

H. Kazazian, A. Maggio, C. Dowling, 1988 .

Efficacy of ruxolitinib as inducer of fetal hemoglobin in primary erythroid cultures from sickle cell and beta-thalassemia patients

A. Maggio, A. Pecoraro, A. Troia, 2019, Thalassemia Reports.

β‐Thalassemia Mutations in Sicily a

H. Kazazian, F. Trapani, A. Maggio, 1990, Annals of the New York Academy of Sciences.

Age at diagnosis as an indicator of eligibility for BRCA1 DNA testing in familial breast cancer

H. Kazazian, F. Chehab, F. Trapani, 2004, Human Genetics.

Study on the Efficacy of a JAK Inhibitor Pharmacological Agent As Inducer of Fetal Hemoglobin Production in Cultured Erythroid Precursors from Sickle Cell and Beta-Thalassemia Patients

R. Maggio, A. Maggio, A. Pecoraro, 2015 .